局部晚期乳腺癌的切线容积旋转调强放疗
研究纳入10例既往接受辅助放疗的左乳癌患者,对比双等中心三野三维适形放疗与单等中心切线容积旋转调强放疗(tVMAT)计划,处方均为50 Gy/25次。tVMAT在靶区适形性、淋巴结覆盖及心脏和左肺保护上均优于三维适形放疗。
要点
- tVMAT较三维适形放疗提高乳腺及区域淋巴结覆盖均匀性(适形指数1.42 vs 2.42,P<.01)。
- tVMAT降低左肺V20Gy(15.0% vs 24.6%,P<.01)和心脏平均剂量(156 cGy vs 200 cGy,P<.01)。
- 作者认为tVMAT是治疗完整乳腺及区域淋巴引流区的有前景技术。
核心结论
- 切线容积旋转调强放疗是治疗完整乳腺及区域淋巴引流区的有前景技术,可能较三维适形技术改善靶区覆盖和危及器官保护。
研究设计与样本
- 选取10例既往接受辅助放疗的左乳癌患者,放疗覆盖乳腺及腋窝和锁骨上淋巴结区域,为每例患者创建双等中心三野三维适形放疗计划和单等中心tVMAT计划,两者处方均为50 Gy/25次。
主要发现
- tVMAT较三维适形放疗提供更均匀的乳腺和区域淋巴结覆盖(平均适形指数:tVMAT 1.42 vs 三维适形放疗 2.42,P<.01)。
- tVMAT的最大点剂量平均更低(tVMAT 112.8% vs 三维适形放疗 121.5%,P<.001)。
- tVMAT对淋巴结覆盖更优(整个淋巴结靶区95%体积的平均最小覆盖:tVMAT为处方剂量的99.5% vs 三维适形放疗94.9%,P<.001)。
- tVMAT改善危及器官保护,左肺平均V20Gy更低(tVMAT 15.0% vs 三维适形放疗24.6%,P<.01),心脏平均剂量更低(tVMAT 156 cGy vs 三维适形放疗200 cGy,P<.01)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cardiovascular toxicity from breast radiation therapy (RT) is a concern to patients and providers. Herein, we present a cardiac-sparing strategy using tangential volumetric modulated arc therapy (tVMAT) in comparison with standard 3-dimensional conformal RT. Ten patients with left-sided breast cancer previously treated with adjuvant RT covering the breast, as well as the axillary and supraclavicular nodal regions, were selected for the study. For each patient, 2 plans were created: a dual-isocenter 3-field 3-dimensional conformal RT plan and a monoisocentric tVMAT plan. The prescription for both techniques was 50 Gy in 25 fractions to the breast and nodal target volumes. Compared with 3-dimensional conformal RT, tVMAT provided more uniform coverage to the breast and regional lymph nodes (mean conformity index: 1.42 for tVMAT vs 2.42 for 3-dimensional conformal RT; P < .01), and the maximum point dose for tVMAT was lower on average (112.8% for tVMAT vs 121.5% for 3-dimensional conformal RT; P < .001). Coverage to the lymph nodes was superior for tVMAT (average minimum coverage to 95% of entire nodal target volumes: 99.5% of prescribed dose for tVMAT vs 94.9% for 3-dimensional conformal RT; P < .001). Organ-at-risk sparing was improved with tVMAT, with a lower average V20Gy for the left lung (15.0% for tVMAT vs 24.6% for 3-dimensional conformal RT; P < .01) and lower mean heart dose (156 cGy for tVMAT vs 200 cGy for 3-dimensional conformal RT; P < .01). Tangential volumetric modulated arc therapy is a promising technique for the treatment of intact breast and regional lymphatics, and it may improve target coverage and organ-at-risk avoidance compared with 3-dimensional conformal techniques.
引用
- Zamora PL, Baran G, Nagle C, et al. Tangential Volumetric Modulated Arc Therapy for Locally Advanced Breast Cancer. Pract Radiat Oncol. 2021. PMID: 34902636. doi:10.1016/j.prro.2021.11.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。